Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00604552 · ClinicalTrials.gov registry record · NA
AneuRx Post Market Study in the Treatment of AAA
A NA study, sponsored by Medtronic Cardiovascular.
- Terminated
- Registry status
- NA
- Development phase
- 349
- Enrollment target
NCT00604552 is a NA study that was terminated before completion, run by Medtronic Cardiovascular. The registered enrollment target is 349 participants.
The verdict
NCT00604552, a NA study, was terminated before completion, sponsored by Medtronic Cardiovascular.
- TERMINATED
- Registry status
- NA
- Development phase
- 349 participants
- Enrollment target
Study Summary
The aorta is a large blood vessel that carries blood away from the heart to the organs in the rest of the body. An aneurysm is a weakening in the artery wall that will become a bulge in the aorta. If left untreated, this bulge may continue to grow larger and may rupture (break open) with fatal consequences. Abdominal aortic aneurysm (AAA) is a life-threatening lesion that has been treated in recent year via endovascular repair. The purpose of this study is to monitor the long term performance of the AneuRx Stent Graft Systems.
Interventions
- DEVICE AneuRx Stent Graft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 349 participants |
| Start Date | 2003-07 |
| Est. Completion | 2009-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00604552
The ClinicalTrials.gov registry entry for NCT00604552 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 349 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiovascular, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AneuRx Stent Graft is the first listed.
NCT00604552 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00604552 about?
NCT00604552 is a clinical study titled "AneuRx Post Market Study in the Treatment of AAA". The aorta is a large blood vessel that carries blood away from the heart to the organs in the rest of the body. An aneurysm is a weakening in the artery wall that will become a bulge in the aorta. If left untreated, this bulge may continue to grow larger and may rupture (break open) with fatal conse...
What is the current status of trial NCT00604552?
This trial is currently terminated. It is a NA study. The enrollment target is 349 participants. The study started on 2003-07. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00604552?
The interventions under investigation include: AneuRx Stent Graft (DEVICE).
Who is sponsoring clinical trial NCT00604552?
This trial is sponsored by Medtronic Cardiovascular, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.